Financials
Financial year 2025
CABINET MEDICAL TYMPANUM from Schaarbeek, company number BE0461622406, closed financial year 2025 with a result of € 11,613 after tax. For that financial year CABINET MEDICAL TYMPANUM recorded a gross margin of € 41,370 and equity of € 250,569. Compared with financial year 2024, the result moved from € 27,985 to € 11,613. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 250,569
▲ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 11,613
▼ 59% vs 2024
Profit after tax over the fiscal year.
€ 94,558
▼ 4% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 244,371.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 59,830
▼ 9% vs 2024
€ 13,595 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 4,633
Supplier invoices still open on the last day of the fiscal year.
€ 209
▼ 98% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 98,659 | € 77,736 | € 51,719 | € 41,370 | ▼ 20% |
| Profit after taxes | € 60,318 | € 42,270 | € 27,985 | € 11,613 | ▼ 59% |
| Equity | € 168,701 | € 210,971 | € 238,956 | € 250,569 | ▲ 5% |
| Total debts | € 97,613 | € 89,757 | € 75,221 | € 64,672 | ▼ 14% |
| Cash | € 92,255 | € 103,642 | € 98,747 | € 94,558 | ▼ 4% |
| Land & buildings | € 140,364 | € 136,287 | € 132,210 | € 127,680 | ▼ 3% |
| Retained profit | € 162,503 | € 204,774 | € 232,759 | € 244,371 | ▲ 5% |
| Bank debt | € 86,211 | € 75,631 | € 65,871 | € 59,830 | ▼ 9% |
| Balance sheet total | € 266,314 | € 300,728 | € 314,177 | € 315,241 |
Key figures of CABINET MEDICAL TYMPANUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about CABINET MEDICAL TYMPANUM the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to CABINET MEDICAL TYMPANUM?
What happened at CABINET MEDICAL TYMPANUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 11,613 (▼ 59% vs 2024). filed late Source: NBB ↗
- Seyed Reza Sheikholeslamzadeh became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 60,318 profit in 2022 to € 11,613 profit in 2025.
Paid € 60,193 in corporate taxes since 2022.
Best year ever: 2022, with € 60,318 profit.
Management
Behind CABINET MEDICAL TYMPANUM is Seyed Reza Sheikholeslamzadeh.
Directors
According to the 2025 annual accounts
Seyed Reza Sheikholeslamzadeh
Director
since 2026
Establishments
Establishment units
Physical locations of this company
Paul Deschanellaan 121 box 11
1030 Schaarbeek
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0461.622.406
- VAT number
- BE 0461.622.406
- Registered office
- Paul Deschanellaan 121 bus 11, 1030 Schaarbeek
- Names & denominations
- CABINET MEDICAL TYMPANUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 October 1997
- Peppol
- Active · Active since 22 Jan 2026
- Contact
- [email protected]